Literature DB >> 10075318

Report of a National Institutes of Health--Centers for Disease Control and Prevention workshop on the feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons.

S Z Yanovski1, R P Bain, D F Williamson.   

Abstract

A workshop was convened in 1997 by the National Institutes of Health and the Centers for Disease Control and Prevention to consider the need for and feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons. Although the benefits of weight loss in obese individuals may seem obvious, little information is available showing that intentional weight loss improves long-term health outcomes. Observational studies may be unable to provide convincing answers about the magnitude and direction of the health effects of intentional weight loss. Workshop participants agreed that a well-designed randomized clinical trial could answer several questions necessary for developing a rational clinical and public health policy for treating obesity. Such information will ultimately provide needed guidance on the risks and benefits of weight loss to health care providers and payers, as well as to millions of obese Americans.

Entities:  

Mesh:

Year:  1999        PMID: 10075318     DOI: 10.1093/ajcn/69.3.366

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  8 in total

1.  Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.

Authors:  Gitte Hansen; Jacob Jelsing; Niels Vrang
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  Action for health in diabetes: the look AHEAD clinical trial.

Authors:  David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 3.  Mortality rate and overweight: Overblown or underestimated? A commentary on a recent meta-analysis of the associations of BMI and mortality.

Authors:  Scott W Keith; Kevin R Fontaine; David B Allison
Journal:  Mol Metab       Date:  2013-03-25       Impact factor: 7.422

Review 4.  The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.

Authors:  Gareth R Dutton; Cora E Lewis
Journal:  Prog Cardiovasc Dis       Date:  2015-04-30       Impact factor: 8.194

Review 5.  Risk of Type 2 Diabetes Among Individuals with Excess Weight: Weight Trajectory Effects.

Authors:  Arthur H Owora; David B Allison; Xuan Zhang; Nana Gletsu-Miller; Kishore M Gadde
Journal:  Curr Diab Rep       Date:  2022-07-04       Impact factor: 5.430

6.  Improving management of obesity in primary care: cluster randomised trial.

Authors:  Helen Moore; Carolyn D Summerbell; Darren C Greenwood; Philip Tovey; Jacqui Griffiths; Maureen Henderson; Kate Hesketh; Sally Woolgar; Ashley J Adamson
Journal:  BMJ       Date:  2003-11-08

7.  Present and future: pharmacologic treatment of obesity.

Authors:  Mariela Glandt; Itamar Raz
Journal:  J Obes       Date:  2011-02-08

8.  Obesity: prevalence, theories, medical consequences, management, and research directions.

Authors:  Colin Wilborn; Jacqueline Beckham; Bill Campbell; Travis Harvey; Melyn Galbreath; Paul La Bounty; Erika Nassar; Jennifer Wismann; Richard Kreider
Journal:  J Int Soc Sports Nutr       Date:  2005-12-09       Impact factor: 5.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.